IllustrativeWhy Jazz Pharmaceuticals Stock’s EPS is Set to 3x in 2026
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Jazz Pharmaceuticals' earnings per share is expected to triple. This increase is anticipated to occur in 2026. The reason for this projected growth is not specified.